Anyone who has ever experienced cellulite knows that it can be a frustrating aesthetic concern. Cellulite is caused by fibrous bands of connective tissue that pull skin down and cause depressions to form. It usually manifests as “dimpled” flesh on the thighs, buttocks, or elsewhere on the body. Cellulite can occur in varying degrees of severity and can be very stubborn, typically not responding to traditional weight loss methods. In the United States, it is especially common in women between the ages of 24 to 54.
Patients suffering from large amounts of cellulite are often deemed candidates for Cellfina™, a non-surgical treatment that directly targets the fibrous tissue responsible for cellulite. For those with less pronounced cellulite, however, Dr. Mark Pinsky and Dr. Vincent Chavanon offer another FDA-cleared method – Avéli™ – at our plastic surgery practice.
Avéli™ is an exciting new technology that, with extreme precision, targets the connective tissue bands that cause cellulite to develop. During the procedure, a small handheld device is inserted into the treatment area to first identify the offending fibrous band(s) and then sever them, releasing the tension and diminishing or eliminating the appearance of cellulite. The process is generally completed in an hour or less, with full results developing approximately a month after the procedure.
The Avéli™ procedure is considered minimally-invasive and relatively quick. After marking the dimpled areas to be addressed, one of the providers at Pinsky Plastic Surgery will apply a local anesthetic. The handheld Avéli™ device will then be inserted under the skin, detecting the particular bands to be targeted in the area. The tool is then utilized to gently divide and release the bands.